S 889 United States Senate · 117th Congress

Prescription Drug Monitoring Act of 2021

Summary
Prescription Drug Monitoring Act of 2021 This bill imposes, as a condition on certain federal funding for the Prescription Drug Monitoring Program (PDMP), additional notification and reporting requirements concerning prescriptions for potentially addictive drugs. States or territories that receive this funding must require prescribers to consult the PDMP before starting treatment with such drugs, and dispensers to report within 24 hours to the PDMP each time they fill a prescription for such drugs. In addition, the state agency administering a PDMP must analyze reported data for patterns of prescription drug misuse or abuse and provide certain information to prescribers, law enforcement, the public, and other states and territories.
Bill status in committee 1 of 4 stages cleared
Introduction
Mar 2021
Committee Review
Floor Vote
President
Introduced Mar 22, 2021 Last action Mar 22, 2021
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
1
Mar 22, 2021
Committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
upper
Mar 22, 2021
Introduced
Introduced in Senate
upper
1 primary · 3 co-sponsors

Sponsors